WO2006028835A3 - Use of thyroid hormone conversion inhibitors - Google Patents
Use of thyroid hormone conversion inhibitors Download PDFInfo
- Publication number
- WO2006028835A3 WO2006028835A3 PCT/US2005/030919 US2005030919W WO2006028835A3 WO 2006028835 A3 WO2006028835 A3 WO 2006028835A3 US 2005030919 W US2005030919 W US 2005030919W WO 2006028835 A3 WO2006028835 A3 WO 2006028835A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- thyroid hormone
- conversion inhibitors
- hormone conversion
- inhibitors
- admixtures
- Prior art date
Links
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 title abstract 2
- 238000006243 chemical reaction Methods 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 239000005495 thyroid hormone Substances 0.000 title abstract 2
- 229940036555 thyroid hormone Drugs 0.000 title abstract 2
- 230000003463 hyperproliferative effect Effects 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0514815-4A BRPI0514815A (en) | 2004-09-01 | 2005-08-30 | method for treating a hyperproliferative skin disorder, and, pharmaceutical composition |
AU2005282789A AU2005282789A1 (en) | 2004-09-01 | 2005-08-30 | Use of thyroid hormone conversion inhibitors |
JP2007530295A JP2008511660A (en) | 2004-09-01 | 2005-08-30 | How to use thyroid hormone conversion inhibitors |
CA002578999A CA2578999A1 (en) | 2004-09-01 | 2005-08-30 | Use of thyroid hormone conversion inhibitors |
EP05792833A EP1789032A4 (en) | 2004-09-01 | 2005-08-30 | Use of thyroid hormone conversion inhibitors |
US11/661,479 US20090082451A1 (en) | 2004-09-01 | 2005-08-30 | Use of thyroid hormone conversion inhibitors |
MX2007002451A MX2007002451A (en) | 2004-09-01 | 2005-08-30 | Use of thyroid hormone conversion inhibitors. |
IL181593A IL181593A0 (en) | 2004-09-01 | 2007-02-27 | Use of thyroid hormone conversion inhibitors |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60648104P | 2004-09-01 | 2004-09-01 | |
US60/606,481 | 2004-09-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006028835A2 WO2006028835A2 (en) | 2006-03-16 |
WO2006028835A3 true WO2006028835A3 (en) | 2007-08-30 |
Family
ID=36036840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/030919 WO2006028835A2 (en) | 2004-09-01 | 2005-08-30 | Use of thyroid hormone conversion inhibitors |
Country Status (13)
Country | Link |
---|---|
US (1) | US20090082451A1 (en) |
EP (1) | EP1789032A4 (en) |
JP (1) | JP2008511660A (en) |
KR (1) | KR20070083612A (en) |
CN (1) | CN101090740A (en) |
AU (1) | AU2005282789A1 (en) |
BR (1) | BRPI0514815A (en) |
CA (1) | CA2578999A1 (en) |
IL (1) | IL181593A0 (en) |
MX (1) | MX2007002451A (en) |
RU (1) | RU2007111760A (en) |
WO (1) | WO2006028835A2 (en) |
ZA (1) | ZA200701800B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009015366A2 (en) * | 2007-07-26 | 2009-01-29 | Trustees Of Boston University | Use of thyroid hormone conversion inhibitors to treat hyperproliferative disorders |
US20130190317A1 (en) * | 2010-08-06 | 2013-07-25 | Galderma Research & Development Snc | Combination of compounds for treating or preventing skin diseases |
US10435365B2 (en) | 2014-03-16 | 2019-10-08 | Hadasit Medical Research Services And Development Ltd. | Type III deiodinase inhibitors and uses thereof |
IT202100014333A1 (en) * | 2021-06-01 | 2022-12-01 | Materias S R L | New therapeutic use of iodine deiodinase type 2 (D2) inhibitors |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6599448B1 (en) * | 2000-05-10 | 2003-07-29 | Hydromer, Inc. | Radio-opaque polymeric compositions |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3966967A (en) * | 1973-03-21 | 1976-06-29 | The Regents Of The University Of California | Compositions and methods of treating psoriasis with vinyligs of desmethyl retinoic acid |
US4021573A (en) * | 1974-04-22 | 1977-05-03 | The Regents Of The University Of California | Psoriasis treatment with retinoic acid analogs |
US3934028A (en) * | 1974-04-22 | 1976-01-20 | The Regents Of The University Of California | Acne and psoriasis treatment with retinoic acid analogs |
US4216224A (en) * | 1978-09-22 | 1980-08-05 | Scott Eugene J Van | Methods and compositions for treating psoriasis with retinoyl compounds |
JPS6044250B2 (en) * | 1981-10-02 | 1985-10-02 | 日本鉱業株式会社 | Arsenous acid manufacturing method |
DE3612305A1 (en) * | 1986-04-11 | 1987-10-22 | Roehm Pharma Gmbh | LIQUID MEDICINE FOR THERAPY OF PSORIASIS BASED ON FILM-FORMING POLYMERS |
TW218849B (en) * | 1991-05-17 | 1994-01-11 | Bristol Myers Squibb Co | |
US5498636A (en) * | 1992-03-13 | 1996-03-12 | Ribogene, Inc. | Treatment of angina pectoris |
US5310742A (en) * | 1992-11-30 | 1994-05-10 | Elias Alan N | Uses for thioureylenes |
GB0015205D0 (en) * | 2000-06-21 | 2000-08-09 | Karobio Ab | Bioisosteric thyroid receptor ligands and method |
EP1358175A2 (en) * | 2001-02-08 | 2003-11-05 | Karo Bio Ab | Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands |
TW532210U (en) * | 2002-02-20 | 2003-05-11 | Chen-Wen Wang | Locking device for a detachable skate of sports shoe |
AU2003228819A1 (en) * | 2002-05-03 | 2003-11-17 | Combinatorx, Incorporated | Combinations for the treatment of inflammatory skin disorders |
US6747048B2 (en) * | 2002-05-08 | 2004-06-08 | Bristol-Myers Squibb Company | Pyridine-based thyroid receptor ligands |
-
2005
- 2005-08-30 MX MX2007002451A patent/MX2007002451A/en not_active Application Discontinuation
- 2005-08-30 JP JP2007530295A patent/JP2008511660A/en active Pending
- 2005-08-30 RU RU2007111760/14A patent/RU2007111760A/en not_active Application Discontinuation
- 2005-08-30 CN CNA2005800381017A patent/CN101090740A/en active Pending
- 2005-08-30 EP EP05792833A patent/EP1789032A4/en not_active Withdrawn
- 2005-08-30 CA CA002578999A patent/CA2578999A1/en not_active Abandoned
- 2005-08-30 BR BRPI0514815-4A patent/BRPI0514815A/en not_active IP Right Cessation
- 2005-08-30 US US11/661,479 patent/US20090082451A1/en not_active Abandoned
- 2005-08-30 AU AU2005282789A patent/AU2005282789A1/en not_active Abandoned
- 2005-08-30 WO PCT/US2005/030919 patent/WO2006028835A2/en active Application Filing
- 2005-08-30 KR KR1020077007242A patent/KR20070083612A/en not_active Application Discontinuation
-
2007
- 2007-02-27 IL IL181593A patent/IL181593A0/en unknown
- 2007-02-28 ZA ZA200701800A patent/ZA200701800B/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6599448B1 (en) * | 2000-05-10 | 2003-07-29 | Hydromer, Inc. | Radio-opaque polymeric compositions |
Also Published As
Publication number | Publication date |
---|---|
KR20070083612A (en) | 2007-08-24 |
US20090082451A1 (en) | 2009-03-26 |
CA2578999A1 (en) | 2006-03-16 |
IL181593A0 (en) | 2008-06-05 |
CN101090740A (en) | 2007-12-19 |
EP1789032A4 (en) | 2008-07-30 |
EP1789032A2 (en) | 2007-05-30 |
JP2008511660A (en) | 2008-04-17 |
MX2007002451A (en) | 2007-05-11 |
WO2006028835A2 (en) | 2006-03-16 |
ZA200701800B (en) | 2008-09-25 |
AU2005282789A1 (en) | 2006-03-16 |
RU2007111760A (en) | 2008-10-10 |
BRPI0514815A (en) | 2008-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006003388A3 (en) | Compositions and methods for treating inflammatory disorders | |
WO2006063048A3 (en) | Ibudilast for treating neuropathic pain and associated syndromes | |
HK1122803A1 (en) | ||
MY169564A (en) | Substituted dihydropyrazolones and their use | |
EP1727530A4 (en) | Topical formulations for the treatment of skin conditions | |
WO2006014930A3 (en) | Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation | |
WO2005103041A3 (en) | Treatment of cns disorders using cns target modulators | |
WO2007005758A3 (en) | Methods , compositions and devices for promoting angiogenesis | |
WO2007020103A3 (en) | Novel use of peptide compounds for treating muscle pain | |
IL189008A0 (en) | Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders | |
WO2012064667A3 (en) | Treatment of addiction and impulse-control disorders using pde7 inhibitors | |
TW200621765A (en) | Substituted phenylaminothiazoles and their use | |
WO2006004684A3 (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
WO2006127525A3 (en) | Proteasome inhibitors and uses thereof | |
WO2006039691A3 (en) | Morphine and morphine precursors | |
WO2010068794A3 (en) | Hif inhibitors and use thereof | |
WO2005117979A3 (en) | Use of il-17 in the treatment of fertility-related disorders | |
WO2005117939A3 (en) | Use of GPCR54 ligands for the treatment of infertility | |
WO2009079451A3 (en) | Compositions and methods of promoting wound healing | |
GB2445674B (en) | Compositions for the topical treatment of eczema, psoriasis and the like | |
WO2007084753A3 (en) | Skin cleansing article | |
WO2006089664A3 (en) | Heterocyclylamide-substituted imidazoles | |
WO2009136997A3 (en) | Inhibitors of human cathepsin l, cathepsin b, and cathepsin s | |
WO2006028835A3 (en) | Use of thyroid hormone conversion inhibitors | |
WO2004087700A8 (en) | Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 181593 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2007/002451 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2578999 Country of ref document: CA Ref document number: 2007530295 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 553788 Country of ref document: NZ Ref document number: 2005282789 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005792833 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077007242 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007111760 Country of ref document: RU Ref document number: 1346/CHENP/2007 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2005282789 Country of ref document: AU Date of ref document: 20050830 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005282789 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580038101.7 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2005792833 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0514815 Country of ref document: BR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11661479 Country of ref document: US |